1 ご挨拶・講演等.indd



Similar documents
yamato_2016_0915_色校_CS3.indd

ジェネリック医薬品販売会社(田辺製薬販売株式会社)の設立に伴う包装変更のご案内

06地図目録.pwd

17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) (1) (3) 25. (1) (3) 26. (1) 27. (1) (3) 28. (1) 29. (1) 2

<4D F736F F D2081A193B98BE EA97708CFB8DC08B4B92E D8D878CFB8DC0817A B4B816A81798A6D92E894C5817A2E646F63>


( )


夏目小兵衛直克



221 1

PowerPoint Presentation

TD-C56D.indd

t Z

untitled

(1)

DV-AR11s

P s.....v..

Microsoft Word - Documento2

-2-


/ 30 / - 2 -

38


NGO/NPO Web



理解のための教材開発と授業 (宮内).PDF

橡魅力ある数学教材を考えよう.PDF

untitled

ٽ’¬24flNfix+3mm-‡½‡¹724

取扱説明書 [F-08D]


untitled


Microsoft Word - 教材ガイド一覧ビデオ.doc

2




untitled

32


10st_jp_p43_44.indd

スライド 1


() () () () kcal/100g /100g /100g () mg/100g mg/100g g/100g 100 DHA DHA

斡旋CDリスト.xls

199004_渓仁会_年次報告書

からだにeヘルシーレシピ 高血圧

石井.PDF

untitled

取扱説明書 [F-01F]

Transcription:

8 28 D 1313 9 00 9 40-1 O-001 O-002 O-003 LDL O-004 LDL LDL O-005

8 28 D 1313 9 40 10 20-2 O-006 O-007 O-008 B 1 O-009 O-010 -

8 28 D 1313 10 20 10 52-1 O-011 O-012 5 O-013 3 O-014 CKD 24

8 28 D 1313 10 52 116-2 O-015 1 O-016 O-017 2 5

8 28 D 1313 116 140 O-018 O-019 O-020 BH4

8 28 1313 9 00 9 32 1 O-021 O-022 O-023 O-024 LDL 9 32 9 56 2 O-025 CD 5 O-026 L O-027

8 28 1313 9 56 10 28-1 O-028 O-029 O-030 4 O-031 L-

8 28 1313 10 28 108-2 O-032 O-033 5 O-034 O-035 Phase angle Resistance BIA 2 O-036

8 28 1313 108 148 O-037 GI 5 O-038 2 5 6 O-039 ICU O-040 O-041 REF-P

8 28 D 1313 15 00 15 40 O-042 O-043 O-044 O-045 O-046

8 28 D 1313 15 40 16 12-1 O-047 O-048 O-049 O-050 1

8 28 D 1313 16 12 16 36-2 O-051 O-052 CAPD BIA BNP O-053 4 0.4g/

8 28 D 1313 16 36 17 08 O-054 Web O-055 C O-056 B 5 6 O-057

8 28 D 1313 17 08 17 48 O-058 O-059 5 6 O-060 O-061 IBD1 O-062 IBD2

8 28 1313 15 00 15 32-1 O-063 O-064 O-065 O-066 R 5

8 28 1313 15 32 16 12-2 O-067 O-068 GABA O-069 O-070 O-071

8 28 1313 16 12 16 52-1 O-072 GI O-073 O-074 Lactobacillus rhamnosus GG O-075 O-076

8 28 1313 16 52 17 32-2 O-077 O-078 O-079 O-080-5 O-081 CoQ10- CD 5

8 29 D 1313 10 40 128 O-082 5 6 O-083 2 2 O-084 O-085 2 3 O-086 3AR, UCP1, AGT MTHFR O-087

8 29 D 1313 128 100 O-088 O-089 O-090 =PWV O-091 =IMT

8 29 E 1313 9 00 9 40-1 O-092 O-093 O-094 1 O-095 MNA-SF O-096

8 29 E 1313 9 40 10 20-2 O-097 O-098 5 6 7 8 9 10 1 1 O-099 O-100 O-101

8 29 E 1313 10 20 100-3 O-102 O-103 O-104 O-105 O-106 LDL-

8 29 E 1313 100 140-4 NST O-107 O-108 O-109 O-110 O-111

8 29 D 1313 15 30 16 10 NST-1 O-112 NST 1 O-113 NST O-114 NST O-115 NST O-116

8 29 D 1313 16 10 16 42 NST-2 O-117 NST NST O-118 5 6 O-119 NST O-120 Controlling Nutritional Status CONUT 5 6